The West Pharmaceutical Services, Inc. (WST) revenue growth is (1.7%), which is lower than the industry median of 3.7% and the 5-year historical average of 11.2%.
The West Pharmaceutical Services, Inc. (WST) operating income growth is (6.2%), compared to the industry median of 9.8% and the 5-year historical average of 23.1%.
The West Pharmaceutical Services, Inc. (WST) EPS growth is (9.4%), compared to the industry median of 9.8% and the 5-year historical average of 24.8%.
The West Pharmaceutical Services, Inc. (WST) Free Cash Flow growth is (23.4%), compared to the industry median of 4.9% and the 5-year historical average of 14.8%.